Innophos Holdings, Inc. (IPHS) Position Boosted by Dalton Greiner Hartman Maher & Co.

Dalton Greiner Hartman Maher & Co. boosted its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 41.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,140 shares of the specialty chemicals company’s stock after buying an additional 16,317 shares during the period. Dalton Greiner Hartman Maher & Co.’s holdings in Innophos were worth $2,623,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in IPHS. Schwab Charles Investment Management Inc. lifted its holdings in Innophos by 16.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 222,410 shares of the specialty chemicals company’s stock valued at $9,751,000 after buying an additional 31,129 shares during the period. Rhumbline Advisers lifted its holdings in Innophos by 1.2% in the second quarter. Rhumbline Advisers now owns 39,776 shares of the specialty chemicals company’s stock valued at $1,744,000 after buying an additional 456 shares during the period. Bank of New York Mellon Corp lifted its holdings in Innophos by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 372,191 shares of the specialty chemicals company’s stock valued at $16,316,000 after buying an additional 5,633 shares during the period. Legal & General Group Plc lifted its holdings in Innophos by 8.4% in the second quarter. Legal & General Group Plc now owns 36,458 shares of the specialty chemicals company’s stock valued at $1,599,000 after buying an additional 2,825 shares during the period. Finally, BNP Paribas Arbitrage SA lifted its holdings in Innophos by 59.2% in the second quarter. BNP Paribas Arbitrage SA now owns 9,290 shares of the specialty chemicals company’s stock valued at $407,000 after buying an additional 3,454 shares during the period. Institutional investors and hedge funds own 94.46% of the company’s stock.

Several equities analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Innophos from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 4th. KeyCorp restated a “hold” rating on shares of Innophos in a report on Wednesday, November 1st. Finally, BidaskClub upgraded shares of Innophos from a “hold” rating to a “buy” rating in a report on Friday, December 22nd.

Innophos Holdings, Inc. (NASDAQ:IPHS) opened at $46.94 on Friday. Innophos Holdings, Inc. has a fifty-two week low of $41.66 and a fifty-two week high of $58.22. The firm has a market cap of $906.15, a PE ratio of 21.53 and a beta of 0.85. The company has a current ratio of 2.86, a quick ratio of 1.49 and a debt-to-equity ratio of 0.83.

Innophos (NASDAQ:IPHS) last announced its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.06. Innophos had a net margin of 6.19% and a return on equity of 13.90%. The firm had revenue of $184.00 million for the quarter, compared to analyst estimates of $179.33 million. During the same quarter in the prior year, the business earned $0.69 earnings per share. The business’s quarterly revenue was down 1.1% compared to the same quarter last year. sell-side analysts forecast that Innophos Holdings, Inc. will post 2.5 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This report was originally published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.com-unik.info/2018/01/12/innophos-holdings-inc-iphs-position-boosted-by-dalton-greiner-hartman-maher-co.html.

About Innophos

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

What are top analysts saying about Innophos? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Innophos and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit